SFA-004

N/A

Report date: 2023/04/20 09:43:30
NME

Base Information

Drug NameSFA-004
Drug Alias NameSFA-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 2 antagonistsFree fatty acid receptor 3 modulators
TargetsFree fatty acid receptor 2Free fatty acid receptor 3
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSFA Therapeutics IncTemple University
China Registration ClassN/A

Develop Information

Active CompaniesSFA Therapeutics IncTemple University
Inactive CompaniesN/A
Active IndicationsUveitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A